|Bid||3.9500 x N/A|
|Ask||4.0250 x N/A|
|Day's Range||4.0600 - 4.0600|
|52 Week Range||3.3650 - 7.0700|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for 1R9.MU
Immunovia will participate in the Cowen 42nd Annual Health Care Virtual Conference on March 9, 2022.
Immunovia AB (publ) announces that Philipp Mathieu has been appointed acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated.